In this guide
What is molybdenum?
Molybdenum is an essential trace element incorporated into molybdopterin, a cofactor for sulfite oxidase, xanthine oxidase, aldehyde oxidase and mitochondrial amidoxime reducing component. These enzymes process sulfur-containing amino acids, purines and other compounds. [1]
The requirement is tiny and ordinary diets usually meet it. Essentiality does not establish a wellness benefit from taking hundreds or thousands of micrograms beyond adequacy.
Typical Molybdenum Protocols
| Purpose or population | Form and amount each time | Frequency | Total per day | Duration |
|---|---|---|---|---|
| U.S. RDA · adults age 19+ | Molybdenum from all sources | Across the day | 45 mcg molybdenum | Ongoing reference intake |
| U.S. RDA · pregnancy / lactation | Molybdenum from all sources | Across the day | 50 mcg molybdenum | Through the applicable life stage |
| U.S. UL · healthy adults age 19+ | Molybdenum from food, beverages and supplements | Across the day | 2,000 mcg molybdenum | Maximum usual daily intake |
These values are intake references. Molybdenum is not a standard treatment for any disease, and the historic acquired-deficiency report does not supply a general regimen. [1]
Why a rare case does not become a protocol
NIH ODS describes one historic acquired-deficiency case in a patient receiving long-term parenteral nutrition without molybdenum. [1]
A single medically complex case does not define a dose, frequency or duration for the general public. Genetic molybdenum cofactor deficiency is also a separate inherited disease, not a retail supplement indication.
One nutrient, three very different contexts
A dietary requirement is not a treatment protocol or a genetic-disease therapy.
Food generally covers the adult RDA of 45 mcg/day.
One historic TPN case cannot define a public regimen.
Cofactor deficiency is distinct and is not treated with an ordinary supplement.
The adult UL of 2,000 mcg/day is a safety boundary, not a target.
Should molybdenum be cycled?
No evidence-based cycling schedule exists. Normal adequacy is continuous, while diagnosed nutrition-support deficiencies require the treating team to correct the full formulation.
What happens when it is stopped?
There is no recognized withdrawal syndrome. Food intake usually continues. A deficiency would recur only if the underlying source problem remained, such as an incomplete parenteral formulation.
Which foods provide molybdenum?
Legumes are among the richest sources; whole grains, nuts and liver also contribute. Food content varies with soil and water. U.S. intake estimates exceed the RDA, and no population group is known to be generally at risk of inadequacy. [1]
Which molybdenum forms are used?
Products use sodium molybdate, ammonium molybdate and molybdenum chelates, often in multivitamin/mineral products. ODS reports no comparative bioavailability studies among supplement forms. Compare elemental molybdenum per serving.
How should molybdenum be stored?
Keep it sealed, dry and away from children. Preserve the label so the elemental amount and all overlapping multivitamin or trace-mineral sources can be counted.
What is molybdenum commonly used for?
Retail products are promoted for detoxification, sulfur sensitivity, energy and general enzyme support. The enzyme role establishes a requirement, but no clinical evidence makes molybdenum a standard treatment for these broad claims. [1]
What does human research show?
Human outcome evidence is sparse. Acquired deficiency has been reported in one person receiving molybdenum-free parenteral nutrition, with symptoms and abnormal sulfur metabolism that improved after the nutrition formulation was corrected. That evidence establishes biological necessity in an extreme context, not an optimization benefit. [1]
Molybdenum cofactor deficiency is an inherited inability to produce the shared cofactor and causes severe neurologic disease early in life. It is not the same as low dietary intake and is not corrected by ordinary molybdenum supplements. [1]
How does molybdenum work?
Absorbed molybdenum helps form molybdopterin cofactor. The kidney is the main route of regulation and excretion, with urinary output rising as intake increases. A biochemical role does not reveal whether a person needs a supplement. [1]
What are the risks and interactions?
Human toxicity evidence is limited. Very high exposure has been associated with gout-like effects in one population, but the adult UL rests mainly on animal reproductive and developmental data. The 2,000 mcg/day limit is a safety boundary, not a target. [1]
ODS lists no clinically relevant medication interactions. Evidence gaps remain, especially for high-dose long-term use, kidney disease and overlapping products.
In the United States, dietary supplements generally lack FDA premarket approval for safety or efficacy. In Canada, natural health products require licensing and authorized labels carry an NPN or DIN-HM. [2], [3]
Which medicines interact with molybdenum?
No clinically relevant medicine interaction is established in the ODS monograph. Still review prescription medicines, kidney function, nutrition support and all trace-mineral products when investigating an unusual exposure.
What should be monitored?
Routine wellness testing is not established. In specialized nutrition-support or metabolic evaluation, clinicians can assess the clinical syndrome, formulation history, sulfur-metabolite pattern and kidney function. A retail mineral panel cannot diagnose molybdenum cofactor deficiency. [1]
What do public communities report?
People discuss sulfur foods, sulfites and “detox” pathways. These reports rarely distinguish food intolerance, enzyme disorders, kidney handling or total dose. This overhaul did not independently recrawl or quantify community posts.
How does molybdenum compare with nearby guides?
| Guide | Main question | Key difference |
|---|---|---|
| Selenium | Selenoproteins, adequacy and narrow margin | Different enzymes and stronger human trial evidence |
| Manganese | Enzyme roles and neurologic toxicity | Much higher intake values and biliary clearance |
| Copper | Adequacy, zinc and Wilson disease | Different biomarkers and inherited excess disorder |
| B-complex | Overlapping B-vitamin totals | Multi-ingredient product rather than a trace element |
Common questions about molybdenum
What is the adult RDA?
45 mcg/day from all sources; pregnancy and lactation use 50 mcg/day. [1]
What is the adult upper limit?
2,000 mcg/day from all sources for healthy adults. It is not a target. [1]
Is deficiency common?
No. Acquired deficiency is represented by one historic long-term parenteral-nutrition case. [1]
Does it treat molybdenum cofactor deficiency?
No. That inherited disorder prevents cofactor synthesis and is distinct from dietary deficiency. [1]
Is one supplement form better absorbed?
No comparative studies establish superior bioavailability among forms. [1]
Does molybdenum “detox” sulfites?
Sulfite oxidase requires the cofactor, but that mechanism does not establish a supplement treatment for nonspecific symptoms.
Why is the UL based on animals?
Human evidence was inadequate, so the Food and Nutrition Board used reproductive and developmental effects in animals. [1]
Glossary
Plain explanations of molybdenum terms.
- Molybdopterin cofactor
- A molecule that holds molybdenum so several enzymes can function.
- Recommended Dietary Allowance (RDA)
- An intake intended to meet the needs of nearly all healthy people in a group.
- Tolerable Upper Intake Level (UL)
- The highest usual intake expected to pose little risk to healthy people.
- Total parenteral nutrition (TPN)
- Nutrition delivered intravenously when the digestive tract cannot be used adequately.
- Sulfite oxidase
- A molybdenum-cofactor enzyme that converts sulfite to sulfate.
- Molybdenum cofactor deficiency
- A severe inherited disorder of cofactor synthesis, distinct from low dietary intake.
How this guide was researched
This draft uses a current full read of the NIH ODS molybdenum monograph and current U.S./Canadian regulatory pages. The monograph supplies the rare-case context and explicitly notes the lack of established disease-treatment use. Relevant text was read on October 9, 2026.
How this guide was made
Research and drafting were AI-assisted. This draft awaits Doserly editorial and independent clinical review. Read the editorial policy.
Explore the sources
Official nutrition and regulatory sources define the current evidence boundaries.
Showing 3 sources
- 01
Molybdenum — Health Professional Fact Sheet ↗
Official nutrient monograph
Current full page reviewed for enzyme roles, RDAs, UL, foods, forms, the historic TPN case, genetic cofactor deficiency and toxicity limits.
Detail: Adult RDA 45 mcg; pregnancy/lactation 50 mcg; adult UL 2,000 mcg/day; no standard disease-treatment use.
- 02
Questions and Answers on Dietary Supplements ↗
Regulatory overview
Current official page reviewed.
Detail: General U.S. supplement framework.
- 03
Product Licensing ↗
Regulatory overview
Current official page reviewed.
Detail: Canadian natural-health-product licensing and NPN or DIN-HM.
No matching sources
Try a different term or show the full list.